The abstract is read at the publisher; the summary is JClub's.
Nine cryo-EM structures of neutralizing monoclonal antibodies bound to rabies virus glycoprotein reveal three known and two additional antigenic sites, including broadly cross-reactive sites V and VI.
- Why it matters: Rabies still kills over 60,000 people per year and imposes billions of dollars in costs, so better vaccine durability and antibody-based treatment are needed.
- What they did: The study solved nine cryo-EM structures of neutralizing mAbs complexed with RABV-G, mapping binding to three established antigenic sites plus two additional ones.
- The result: Sites V and VI are broadly cross-reactive across lyssaviruses, while sites II/IV and III are rabies specific; fusion inhibition and binding affinity correlate best with neutralization.
The findingWhy it mattersWhat they didThe result
AI summary of the abstract · may contain errors · not medical advice · read the paper.